NCT04982406

Brief Summary

This is a prospective observational study, the purpose of which is to:

  1. 1.Characterize response of the AV conduction system to TAVR with various prostheses by recording continuous His bundle electrograms during valve placement.
  2. 2.Correlate preprocedure ECG features with changes in AV nodal and infranodal conduction during placement of the valve prosthesis.
  3. 3.Correlate changes in AV nodal and infranodal conduction during the procedure with risk of developing AV conduction block after TAVR.
  4. 4.Assess the contribution of stressing the conduction system by atrial pacing prior to and following TAVR to prediction of postprocedural heart block.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
409

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 18, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 20, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 29, 2021

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2024

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 21, 2025

Completed
Last Updated

January 24, 2025

Status Verified

January 1, 2025

Enrollment Period

2.7 years

First QC Date

July 20, 2021

Last Update Submit

January 22, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Heart block

    We will prospectively follow patients for the development of heart block requiring permanent pacemaker implantation, and identify factors associated with heart block following TAVR..

    30 days following procedure

Interventions

Transcatheter aortic valve replacement

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with severe aortic stenosis or regurgitation planned to undergo transcatheter aortic valve replacement

You may qualify if:

  • patients undergoing elective TAVR at BIDMC

You may not qualify if:

  • patients with permanent implanted pacemakers or ICDs prior to TA

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alfred Buxton

Boston, Massachusetts, 02215, United States

Location

Related Publications (1)

  • Poulin MF, Ultimo B, Omar W, Rathakrishnan BG, Haouzi A, Pinto DS, Buxton AE, Laham RJ. Routine Electrophysiology Study During Transcatheter Aortic Valve Replacement: A Safety and Feasibility Pilot Study. JACC Cardiovasc Interv. 2023 Oct 23;16(20):2584-2586. doi: 10.1016/j.jcin.2023.07.017. Epub 2023 Sep 20. No abstract available.

MeSH Terms

Conditions

Aortic Valve StenosisHeart Block

Interventions

Transcatheter Aortic Valve Replacement

Condition Hierarchy (Ancestors)

Aortic Valve DiseaseHeart Valve DiseasesHeart DiseasesCardiovascular DiseasesVentricular Outflow ObstructionArrhythmias, CardiacCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Heart Valve Prosthesis ImplantationCardiac Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeProsthesis ImplantationThoracic Surgical Procedures

Study Officials

  • Alfred Buxton, MD

    Beth Israel Deaconess Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Shlomo Ben-Haim, MD - Mark E. Josephson, MD, Professor of Medicine in Field of Cardiac Electrophysiology

Study Record Dates

First Submitted

July 20, 2021

First Posted

July 29, 2021

Study Start

May 18, 2021

Primary Completion

January 30, 2024

Study Completion

January 21, 2025

Last Updated

January 24, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Global Results will be published, not individual patient data

Locations